Subscribe free

HPB & Spleen ·

KRAS Mutations in Duodenal Fluid Detect Resectable Pancreatic Cancer

Using KRAS mutations in duodenal lavage fluid after secretin stimulation offers a promising method for identifying resectable pancreatic ductal adenocarcinoma (PDAC) with high sensitivity.

  • The technique achieved an area under the curve (AUC) of 0.934, indicating excellent discriminatory power between resectable PDAC (89 patients) and healthy controls (75 individuals).
  • Sensitivity for this approach was 83.1% with 100% specificity, outperforming traditional markers like CEA and CA19-9.

This minimally invasive testing could change the early screening landscape for PDAC, emphasizing the importance of genetic mutations in patient management.

Research Support, Non-U.S. Gov’t by Yachida S, Yoshinaga S (…) Matsumoto K et 26 al. in Ann Surg

Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, LLC.

read the whole article in Ann Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

All papers in HPB & Spleen →